tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Alcidion Named Preferred EPR Supplier for Major UK NHS Trust

Story Highlights
  • Alcidion was chosen as preferred supplier of a new EPR system for University Hospitals Sussex, expanding its existing Patientrack relationship.
  • The Miya Precision deployment, expected to exceed A$35m over seven years, strengthens Alcidion’s UK presence and digital health positioning.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Alcidion Named Preferred EPR Supplier for Major UK NHS Trust

Claim 70% Off TipRanks Premium

Alcidion Group Limited ( (AU:ALC) ) has shared an update.

Alcidion Group has been selected as the preferred supplier of a new Electronic Patient Record (EPR) system for University Hospitals Sussex NHS Foundation Trust in the UK, following a competitive tender process. The trust, one of the country’s largest acute providers with seven hospitals and nearly 20,000 staff, already uses Alcidion’s Patientrack solution and will expand this relationship through deployment of the Miya Precision platform, including Miya Observations and Assessments, to deliver real-time access to patient records, streamline patient flow and enhance clinical decision-making. The total contract value is under negotiation but is expected to exceed A$35 million over at least seven years, with deployment targeted to commence in the fourth quarter of FY26, underscoring Alcidion’s strengthening foothold in the UK healthcare market and reinforcing its position as a key digital health partner for large NHS trusts.

The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.

More about Alcidion Group Limited

Alcidion Group Limited is an ASX-listed health IT company that develops smart, intuitive clinical software aimed at improving the efficiency and quality of patient care for healthcare organisations globally. Its flagship Miya Precision platform aggregates clinical data into centralised dashboards, supports interoperability, communication and task management, and delivers clinical decision support at the point of care. With more than 20 years of healthcare experience, Alcidion services over 400 hospitals and 87 healthcare organisations across the UK, Australia and New Zealand, with further international expansion planned.

Average Trading Volume: 647,538

Technical Sentiment Signal: Hold

Current Market Cap: A$134.3M

For a thorough assessment of ALC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1